Embolization and Coiling Devices-Medical Devices Pipeline Assessment, 2017
June 2017
117
About the Report
About the Report
Embolization and Coiling Devices-Medical Devices Pipeline Assessment, 2017
Summary
GlobalData's Medical Devices sector report, "Embolization and Coiling Devices-Medical Devices Pipeline Assessment, 2017" provides an overview of Embolization and Coiling Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Embolization and Coiling Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Embolization and Coiling Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Embolization and Coiling Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Embolization and Coiling Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Products
Aneuclose LLC, Janjua Aneurysm Net; Avantec Vascular Corporation, Endovascular Embolization Device; BioCure, Inc., GelCoil; Collagen Matrix Inc, Collagen-based Coils; DePuy Synthes Inc, Liquid Embolic System; Insera Therapeutics, LLC, SHELTER; Medtronic plc, Medina Embolization Device; Medtronic plc, UNO Neurovascular Embolization System; MicroPort Scientific Corp, Embolization Coils; MicroVention, Inc., Advanced Coil; MicroVention, Inc., Advanced WEB Aneurysm Embolization Device; MicroVention, Inc., WEB Aneurysm Embolization System; MiVi Neuroscience, LLC, Neuronet; Neuravi Ltd, EmboTrap II Revascularization Device; Neuravi Ltd, EmboTrap Revascularization Device; Shape Memory Therapeutics, Inc., Neurovascular Embolization System; Taewoong Medical Co Ltd, K3 Platium Coil; Terumo Corp, VFC /Hydrofill Coil; University of California Los Angeles, Bioactive Endovascular Coil; University of Minnesota, Vascular Embolization Catheter; University of Wisconsin Madison, Bioactive Endovascular Device; Valor Medical Inc, Neucrylate AN; Vascular Solutions Inc, Embolization Device
Companies
Aneuclose LLC, Avantec Vascular Corporation, BioCure, Inc., Collagen Matrix Inc, DePuy Synthes Inc, Insera Therapeutics, LLC, Medtronic plc, MicroPort Scientific Corp, MicroVention, Inc., MiVi Neuroscience, LLC, Neuravi Ltd, Shape Memory Therapeutics, Inc., Taewoong Medical Co Ltd, Terumo Corp, University of California Los Angeles, University of Minnesota, University of Wisconsin Madison, Valor Medical Inc, Vascular Solutions Inc
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Embolization and Coiling Devices Overview 7
3 Products under Development 8
3.1 Embolization and Coiling Devices-Pipeline Products by Stage of Development 8
3.2 Embolization and Coiling Devices-Pipeline Products by Segment 9
3.3 Embolization and Coiling Devices-Pipeline Products by Territory 10
3.4 Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11
3.5 Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12
3.6 Embolization and Coiling Devices-Ongoing Clinical Trials 13
4 Embolization and Coiling Devices-Pipeline Products under Development by Companies 14
4.1 Embolization and Coiling Devices Companies-Pipeline Products by Stage of Development 14
4.2 Embolization and Coiling Devices-Pipeline Products by Stage of Development 15
5 Embolization and Coiling Devices Companies and Product Overview 16
5.1 Aneuclose LLC Company Overview 16
5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Avantec Vascular Corporation Company Overview 17
5.2.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 BioCure, Inc. Company Overview 18
5.3.1 BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Collagen Matrix Inc Company Overview 19
5.4.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 DePuy Synthes Inc Company Overview 20
5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 Insera Therapeutics, LLC Company Overview 21
5.6.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 Medtronic plc Company Overview 22
5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 MicroPort Scientific Corp Company Overview 26
5.8.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 MicroVention, Inc. Company Overview 29
5.9.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 MiVi Neuroscience, LLC Company Overview 35
5.10.1 MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 Neuravi Ltd Company Overview 36
5.11.1 Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 Shape Memory Therapeutics, Inc. Company Overview 40
5.12.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 Taewoong Medical Co Ltd Company Overview 41
5.13.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.14 Terumo Corp Company Overview 43
5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43
5.15 University of California Los Angeles Company Overview 44
5.15.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44
5.16 University of Minnesota Company Overview 45
5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45
5.17 University of Wisconsin Madison Company Overview 46
5.17.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46
5.18 Valor Medical Inc Company Overview 47
5.18.1 Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.19 Vascular Solutions Inc Company Overview 48
5.19.1 Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48
6 Embolization and Coiling Devices- Recent Developments 49
6.1 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 49
6.2 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 49
6.3 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 50
6.4 Apr 25, 2017: Stryker reports first quarter 2017 results 51
6.5 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors 52
6.6 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 53
6.7 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 55
6.8 Mar 30, 2017: MPSC Announces 2016 Annual Results 57
6.9 Mar 07, 2017: MicroVention And Terumo Announce Data From Multicenter GREAT Study 58
6.10 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 59
6.11 Feb 21, 2017: Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke 60
6.12 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 61
6.13 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 64
6.14 Feb 09, 2017: Terumo Announces Change of Executive Officers 65
6.15 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 66
6.16 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 67
6.17 Jan 31, 2017: Terumo Opens a Branch in Yangon 68
6.18 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 68
6.19 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 70
6.20 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 72
6.21 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 74
6.22 Dec 19, 2016: Penumbra Appoints Thomas C. Wilder to its Board of Directors 75
6.23 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 75
6.24 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 76
6.25 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer 79
6.26 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 79
6.27 Nov 15, 2016: Penumbra Announces Resignation of Board Member 80
6.28 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 80
6.29 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results 81
6.30 Oct 27, 2016: Stryker reports third quarter 2016 results 81
6.31 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 83
6.32 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 84
6.33 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 85
6.34 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 88
6.35 Oct 14, 2016: Medtronic Announces Voluntary Recall of Its Pipeline Embolization Device, Alligator Retrieval Device, X-Celerator Hydrophilic Guidewire, Ultraflow and Marathon Flow Directed Micro Catheters 89
6.36 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 90
6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 91
6.38 Sep 07, 2016: Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke 92
6.39 Aug 30, 2016: MPSC Announces 2016 Interim Results 93
6.40 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 94
6.41 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results 97
6.42 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 97
6.43 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 99
6.44 Jul 26, 2016: Merit Medical Announces Appointment of New Director 100
6.45 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 100
6.46 Jul 25, 2016: Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever 103
6.47 Jul 21, 2016: Stryker reports second quarter 2016 results 104
6.48 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 105
6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 107
6.50 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 107
6.51 Jun 24, 2016: Collagen Matrix Names Bill Messer as Vice President, Sales and Marketing 108
6.52 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 108
6.53 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 109
6.54 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 109
6.55 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 110
7 Appendix 114
7.1 Methodology 114
7.2 About GlobalData 117
7.3 Contact Us 117
7.4 Disclaimer 117
List of Figure
1.2 List of Figures
Figure 1: Embolization and Coiling Devices-Pipeline Products by Stage of Development 8
Figure 2: Embolization and Coiling Devices-Pipeline Products by Segment 9
Figure 3: Embolization and Coiling Devices-Pipeline Products by Territory 10
Figure 4: Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11
Figure 5: Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12
Figure 6: Embolization and Coiling Devices-Ongoing Clinical Trials 13
List of Table
1.1 List of Tables
Table 1: Embolization and Coiling Devices-Pipeline Products by Stage of Development 8
Table 2: Embolization and Coiling Devices-Pipeline Products by Segment 9
Table 3: Embolization and Coiling Devices-Pipeline Products by Territory 10
Table 4: Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11
Table 5: Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12
Table 6: Embolization and Coiling Devices-Ongoing Clinical Trials 13
Table 7: Embolization and Coiling Devices Companies-Pipeline Products by Stage of Development 14
Table 8: Embolization and Coiling Devices-Pipeline Products by Stage of Development 15
Table 9: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Janjua Aneurysm Net-Product Status 16
Table 11: Janjua Aneurysm Net-Product Description 16
Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
Table 13: Endovascular Embolization Device-Product Status 17
Table 14: Endovascular Embolization Device-Product Description 17
Table 15: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 16: GelCoil-Product Status 18
Table 17: GelCoil-Product Description 18
Table 18: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 19: Collagen-based Coils-Product Status 19
Table 20: Collagen-based Coils-Product Description 19
Table 21: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 22: Liquid Embolic System-Product Status 20
Table 23: Liquid Embolic System-Product Description 20
Table 24: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 25: SHELTER-Product Status 21
Table 26: SHELTER-Product Description 21
Table 27: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 28: Medina Embolization Device-Product Status 22
Table 29: Medina Embolization Device-Product Description 22
Table 30: UNO Neurovascular Embolization System-Product Status 23
Table 31: UNO Neurovascular Embolization System-Product Description 23
Table 32: Medtronic plc-Ongoing Clinical Trials Overview 24
Table 33: Medina Embolization Device-Medina Embolization Device in Neurovascular Aneurysms Study-A Post Market Clinical Follow-up Study: The MEDINA Study 25
Table 34: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
Table 35: Embolization Coils-Product Status 26
Table 36: Embolization Coils-Product Description 26
Table 37: MicroPort Scientific Corp-Ongoing Clinical Trials Overview 27
Table 38: Embolization Coils-Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms 28
Table 39: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 40: Advanced Coil-Product Status 29
Table 41: Advanced Coil-Product Description 29
Table 42: Advanced WEB Aneurysm Embolization Device-Product Status 30
Table 43: Advanced WEB Aneurysm Embolization Device-Product Description 30
Table 44: WEB Aneurysm Embolization System-Product Status 30
Table 45: WEB Aneurysm Embolization System-Product Description 31
Table 46: MicroVention, Inc.-Ongoing Clinical Trials Overview 32
Table 47: WEB Aneurysm Embolization System-Clinical Assessment of Web Device in Ruptured Aneurysms 33
Table 48: WEB Aneurysm Embolization System-CLinical Assessment of WEB Device in Ruptured aneurysms (CLARYS): CLARYS 33
Table 49: WEB Aneurysm Embolization System-The WEB Intrasaccular Therapy Study (WEB-IT) 33
Table 50: WEB Aneurysm Embolization System-WEB Clinical Assessment of IntraSaccular Aneurysm Therapy 34
Table 51: WEB Aneurysm Embolization System-WEB French Observatory 34
Table 52: MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
Table 53: Neuronet-Product Status 35
Table 54: Neuronet-Product Description 35
Table 55: Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 56: EmboTrap II Revascularization Device-Product Status 36
Table 57: EmboTrap II Revascularization Device-Product Description 36
Table 58: EmboTrap Revascularization Device-Product Status 37
Table 59: EmboTrap Revascularization Device-Product Description 37
Table 60: Neuravi Ltd-Ongoing Clinical Trials Overview 38
Table 61: EmboTrap Revascularization Device-A.R.I.S.E. Analysis of Revascularisation in Ischemic Stroke with EmboTrap: Post Marketing Observational Study of CE Marked EmboTrap Mechanical Thrombectomy Device 39
Table 62: EmboTrap Revascularization Device-ARISE II (Analysis of Revascularization in Ischemic Stroke with EmboTrap) Study 39
Table 63: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 64: Neurovascular Embolization System-Product Status 40
Table 65: Neurovascular Embolization System-Product Description 40
Table 66: Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 67: K3 Platium Coil-Product Status 41
Table 68: K3 Platium Coil-Product Description 42
Table 69: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43
Table 70: VFC /Hydrofill Coil-Product Status 43
Table 71: VFC /Hydrofill Coil-Product Description 43
Table 72: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44
Table 73: Bioactive Endovascular Coil-Product Status 44
Table 74: Bioactive Endovascular Coil-Product Description 44
Table 75: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45
Table 76: Vascular Embolization Catheter-Product Status 45
Table 77: Vascular Embolization Catheter-Product Description 45
Table 78: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46
Table 79: Bioactive Endovascular Device-Product Status 46
Table 80: Bioactive Endovascular Device-Product Description 46
Table 81: Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 82: Neucrylate AN-Product Status 47
Table 83: Neucrylate AN-Product Description 47
Table 84: Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 85: Embolization Device-Product Status 48
Table 86: Embolization Device-Product Description 48
Table 87: Glossary 116
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.